Paper1783523
Antitumor activity and mechanism of action of the marine compound girodazole.
Lavelle F and 4 others. Invest New Drugs, 1991. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Antitumor activity and mechanism of action of the marine compound girodazole. Papers, record 1783523. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1783523
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Imidazoles | Major topic |
| Neoplasms, Experimental | Major topic |
| Propanolamines | Major topic |
| Animals | |
| Cell Division | |
| DNA, Neoplasm | |
| Humans | |
| Leukemia P388 | |
| Mice | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Neoplasm Proteins | |
| Neoplasm Transplantation | |
| Protein Biosynthesis | |
| RNA, Neoplasm | |
| Rabbits | |
| Transcription, Genetic | |
| Tumor Cells, Cultured |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6763877 | Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. | Biochim Biophys Acta | 1982 | https://conductscience.org/library/papers/6763877 | PubMed |
| 2 | 5432063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 3 | 823012 | An efficient mRNA-dependent translation system from reticulocyte lysates. | Eur J Biochem | 1976 | https://conductscience.org/library/papers/823012 | PubMed |
| 4 | 1256442 | Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. | Mol Pharmacol | 1976 | https://conductscience.org/library/papers/1256442 | PubMed |
| 5 | 7011532 | Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin. | Cancer Res | 1981 | https://conductscience.org/library/papers/7011532 | PubMed |
| 6 | 1237080 | Harringtonine, an inhibitor of initiation of protein biosynthesis. | Mol Pharmacol | 1975 | https://conductscience.org/library/papers/1237080 | PubMed |
| 7 | 3001065 | Lycorine: a eukaryotic termination inhibitor? | J Biol Chem | 1986 | https://conductscience.org/library/papers/3001065 | PubMed |
| 8 | 4609488 | Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro. | Biochim Biophys Acta | 1974 | https://conductscience.org/library/papers/4609488 | PubMed |
| 9 | 5238986 | Stimulation of globin-chain initiation by hemin in the reticulocyte cell-free system. | Proc Natl Acad Sci U S A | 1968 | https://conductscience.org/library/papers/5238986 | PubMed |
| 10 | 3896117 | Eukaryotic protein synthesis. | Annu Rev Biochem | 1985 | https://conductscience.org/library/papers/3896117 | PubMed |
| 11 | 4682660 | Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica. | J Org Chem | 1973 | https://conductscience.org/library/papers/4682660 | PubMed |
| 12 | 6681537 | Antiviral and antitumor compounds from tunicates. | Fed Proc | 1983 | https://conductscience.org/library/papers/6681537 | PubMed |
| 13 | 709555 | In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/709555 | PubMed |
| 14 | 3298130 | Is the P388 murine tumor no longer adequate as a drug discovery model? | Invest New Drugs | 1987 | https://conductscience.org/library/papers/3298130 | PubMed |
| 15 | 2720652 | Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. | Cancer Res | 1989 | https://conductscience.org/library/papers/2720652 | PubMed |
| 16 | 6883351 | Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6883351 | PubMed |
| 17 | 6541580 | Do we need new chemosensitive experimental models? | Eur J Cancer Clin Oncol | 1984 | https://conductscience.org/library/papers/6541580 | PubMed |
| 18 | 6656641 | Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA. | Methods Enzymol | 1983 | https://conductscience.org/library/papers/6656641 | PubMed |
| 19 | 2548717 | Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge. | Cancer Res | 1989 | https://conductscience.org/library/papers/2548717 | PubMed |
| 20 | 709550 | Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/709550 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42791378 | Halting translation by the letter with sequence-selective small molecules. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/42791378 | PubMed |
| 39794322 | Girolline is a sequence context-selective modulator of eIF5A activity. | Nat Commun | 2025 | https://conductscience.org/library/papers/39794322 | PubMed |
| 33280581 | A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis. | Biochemistry (Mosc) | 2020 | https://conductscience.org/library/papers/33280581 | PubMed |
| 32041255 | From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds. | Biomolecules | 2020 | https://conductscience.org/library/papers/32041255 | PubMed |
| 25325155 | Evaluation of the toxicity of 5-aryl-2-aminoimidazole-based biofilm inhibitors against eukaryotic cell lines, bone cells and the nematode Caenorhabditis elegans. | Molecules | 2014 | https://conductscience.org/library/papers/25325155 | PubMed |
| 24117378 | Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis. | ACS Chem Biol | 2014 | https://conductscience.org/library/papers/24117378 | PubMed |
| 21556392 | Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids. | Nat Prod Rep | 2011 | https://conductscience.org/library/papers/21556392 | PubMed |
| 19209899 | A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. | J Nat Prod | 2009 | https://conductscience.org/library/papers/19209899 | PubMed |
| 17321546 | The structures of antibiotics bound to the E site region of the 50 S ribosomal subunit of Haloarcula marismortui: 13-deoxytedanolide and girodazole. | J Mol Biol | 2007 | https://conductscience.org/library/papers/17321546 | PubMed |
| 7805184 | Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7805184 | PubMed |
| 1437508 | New cytotoxic drugs and targets in oncology. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1437508 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1783523
GET https://conductscience.org/api/papers/v1/1783523/references?page=2